Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: A comparison with L-Dopa treatment

Movement Disorders

Volumn 11, Issue 6, 1996, Pages 627-632

  Benazzouz, Abdelhamid ^a   Boraud, Thomas ^a   Féger, Jean ^b   Burbaud, Pierre ^a   Bioulac, Bernard ^a   Gross, Christian ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

High frequency stimulation; MPTP; Parkinsonism; Subthalamic nucleus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BENSERAZIDE; BENSERAZIDE PLUS LEVODOPA; LEVODOPA;

AKINESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; DIATHERMY; DYSKINESIA; ELECTROSTIMULATION THERAPY; HEMIBALLISM; HYPOTHALAMUS LESION; INTERMETHOD COMPARISON; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; PARKINSONISM; PRIORITY JOURNAL; RIGIDITY; SUBTHALAMIC NUCLEUS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIPARKINSON AGENTS; DOMINANCE, CEREBRAL; ELECTRIC STIMULATION THERAPY; ELECTROMYOGRAPHY; LEVODOPA; MACACA MULATTA; MOTOR SKILLS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE, SECONDARY; THALAMIC NUCLEI;

EID: 0029846577     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110606     Document Type: Article

References (21)

1. Miller WC, Delong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter MB, Jayarman A, ed. The basal ganglia. New York: Plenum Press, 1987: 415-427.
2. Mitchell IJ, Clarke CE, Boyce S, et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroscience 1989;32:213-226.
3. Robledo P, Féger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electro-physiological data. Brain Res 1990;518:47-54.
4. Graham WC, Robertson RG, Sambrook MA, Crossman AR. Injection of excitatory amino acid antagonists into the pallidal segment of the MPTP-treated primate reverses motor symptoms of parkinsonism. Life Sci 1990;47:91-97.
5. Brotchie JM, Mitchell IJ, Sambrook MA, Crossman AR. Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov Disord 1991;6:133-138.
6. Bergman H, Wichmann T, Delong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1346-1348.
7. Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991;6:288-292.
8. Benazzouz A, Gross C, Feger J, Boraud TH, Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 1993;5:382-389.
9. Meara RJ, Cody FWJ. Relationship between electromyographic activity and clinically assessed rigidity studied at the wrist joint in Parkinson's disease. Brain 1992;115:1167-1180.
10. Benazzouz A, Gross C, Dupont J, Bioulac B. MPTP-induced hemiparkinonism in monkeys: behavioral, mecanographic, electromyographic and immunohistochemical studies. Exp Brain Res 1992;90:116-120.
11. Snider RS, Lee JC. A stereotaxic atlas of the monkey brain (Macaco mulatta). Chicago: The University of Chicago Press, 1961.
12. Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:142-151.
13. Clarke CE, Sambrook MA, Mitchell IJ, Crossman AR. Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J Neurol Sci 1987;78: 273-280.
14. Marsden CD. L-Dopa or bromocriptine for Parkinson's disease, which, how much and when? In: Warlow C, Garfield J, eds. More dilemmas in the management of the neurological patient. London: Churchil Livingstone, 1987:1-7.
15. Hammond C, Féger J, Bioulac B, Souteyrand JP. Experimental hemiballism in the monkey produced by unilateral kainic acid lesion in corpus Luysii. Brain Res 1979;171:577-580.
16. Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J Neurophysiol 1992;68:1850-1858.
17. Sellal F, Hirsch E, Lisovoski F, Mutshler Y, Collard M, Marescaux C. Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology 1992;42:255-256.
18. Féger J, Robledo P, Renwart N. The subthalamic nucleus: new data and new questions. In: Bernardi G, Carpenter MB, Chiara GD, Morelli M, Stanzione P, eds. The basal ganglia III. New York: Plenum Press, 1991:99-108.
19. Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol 1992;68:1859-1866.
20. Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-406.
21. Limousin P, Pollak P, Benazzouz A, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95.